Sandoz Careers
Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.
Sandoz TV
Follow us
Sandoz News
Novartis announces Q4/Full Year 2011 results
Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011
- Read more
- January 25, 2012
Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment
Sandoz announced today that it has initiated two milestone Phase III clinical trials - one for biosimilar filgrastim (Amgen's Neupogen®) in the US market, the other for its global pegfilgrastim development program (Amgen's Neulasta®).
- Read more
- January 19, 2012
Sandoz Quickfinder
Sandoz Websites
- Sandoz Argentina
- Sandoz Australia
- Sandoz Austria
- Sandoz Belgium
- Sandoz Brazil
- Sandoz Canada
- Sandoz China
- Sandoz Croatia
- Sandoz Czech Republic
- Sandoz France
- Sandoz Germany
- Hexal Germany
- 1A Pharma Germany
- Sandoz Hungary
- Sandoz Italy
- Sandoz Japan
- Sandoz Netherlands
- Sandoz Polska
- Sandoz Portugal
- Sandoz Serbia
- Sandoz Slovakia
- Sandoz Slovenia
- Sandoz Switzerland
- Sandoz Turkey
- Sandoz United Kingdom
- Sandoz United States
You are on the website of Sandoz International. Please select from the above dropdown to visit a local website.
You are about to access one of our affiliate websites
Drug regulatory regulations and medical practices can be different from one country to another. As a result the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.
Sandoz History
Take a virtual journey into the historical roots of our company.
Explore our history >-
About Sandoz
Affordable Healthcare
Making a World of Difference
Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population. Learn more about our commitment to patients, doctors and healthcare professionals, as well as the communities in which we live and work. More about Sandoz
-
Quality
Quality
Everyone Can Afford
As part of the Novartis group, we believe that superior quality is key to our long-term success. Our state-of-the-art technologies, decades of experience, and rigorous across-the-board quality standards all contribute to an offer we are justly proud of: quality at a price that everyone can afford. More about our Quality Standards
-
Biosimilars
Pioneering Biosimilars
The Market of the Future
Sandoz was the first company to develop and market follow-on versions of highly complex biopharmaceuticals. Today, we are the undisputed global leader in this segment and have an industry-leading pipeline that will make essential biopharmaceuticals more affordable for all. Discover Sandoz biosimilars
-
Oncology Injectables
Differentiation
Shaping the Future of Healthcare
Going beyond standard generics, we use innovation and expertise to develop even the most complex medicines that add value to patient healthcare – from biosimilars and complex injectables to respiratory and specialty generics. Global access to cost-effective treatment: this is how we are shaping the future of patient healthcare. Read about Sandoz Oncology Injectables
